**PURPOSE:** The purpose of this study was to identify and characterize financial transactions between biomedical companies and plastic surgeons since the implementation of the Sunshine Act.

**METHODS:** We analyzed payment trends using Physician Payment Sunshine Act (PPSA) data (January 2014-December 2017) to assess industry payments made to plastic surgeons over four years published in the Open Payments Program website.

**RESULTS:** In 2014, \$26,709,248 was paid to 5,316 plastic surgeons; the median (IQR) was \$255 (101--660) and mean (SD) was \$5,024 (± 133,531). In 2015, \$19,653,379 was paid to 5,366 plastic surgeons; the median (IQR) was \$298 (110--861) and mean (SD) was \$3,662 (± 67,915). In 2016, \$21,544,043 was paid to 5,308 plastic surgeons; the median (IQR) was \$286 (107- 894) and mean (SD) was \$4,058 (± 68,607). In 2017, \$23,066,378 was paid to 5,384 plastic surgeons; the median (IQR) was \$238 (88--726) and mean (SD) was \$4,284 (± 93,185). The highest payments by payment category were made for royalties and licensing fees: \$13,806,934 in 2014 to 20 plastic surgeons; \$6,974,734 in 2015 to 20 plastic surgeons; \$7,224,323 in 2016 to 22 plastic surgeons; and \$9,168,129 in 2017 to 24 plastic surgeons. The second highest payment category was speaker fees: \$4,976,016 in 2014 to 253 plastic surgeons; \$4,425,901 in 2015 to 295 plastic surgeons; \$3,956,768 in 2016 to 246 plastic surgeons; and \$5,110,970 in 2017 to 201 plastic surgeons. The third highest payment category was consulting fees: \$2,932,708 in 2014 to 292 plastic surgeons; \$2,746,140 in 2015 to 293 plastic surgeons; \$3,500,132 in 2016 to 332 plastic surgeons; and \$3,891,218 in 2017 to 461 plastic surgeons. For four consecutive years Allergan was the highest paying company.

**CONCLUSION:** While the PPSA has been implemented to provide transparency to patients regarding industry's' payments to physicians, its implementation was fraught with speculation that payment trends would change. The 2014--2017 PPSA data demonstrate that there have been minimal changes in payments trends to plastic surgeons over the past four fiscal years.
